Hydroxytyrosol and Parkinson's disease:protective actions against alpha-synuclein toxicity
Ruth Hornedo-Ortega1
Ana M.Espinosa-Oliva2
1.Departamento de Nutrición y Bromatología,Toxicología y Medicina Legal,Facultad de Farmacia,Universidad de Sevilla,Seville,Spain2.Instituto de Biomedicina de Sevilla,IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Sevilla,Spain;Departamento de Bioquímica y Biología Molecular,Facultad de Farmacia,Universidad de Sevilla,Sevilla,Spain
摘要：Parkinson's disease:Parkinson's disease(PD)is the second most prevalent neurodegenerative disease,after Alzheimer's disease,affecting 1％of the general population over the age of 65 years.According to data from the World Health Organization(WHO),its prevalence has doubled in the past 25 years.In 2019,global estimates indicated over 8.5 million individuals with PD and it is suggested that PD caused 329000 deaths,an increase of over 100％since 2000(WHO,2022).Although there are pharmacological interventions that improve the quality of life of PD patients,this brain disorder still has no cure.
机标关键词：parkinsonactionsagainstalpha-synucleindiseasehydroxytyrosolprotectivetoxicity
论文发表日期：2024-07-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 1427-1428 )